A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guaraná in humans.
J Psychopharmacol
; 21(1): 65-70, 2007 Jan.
Article
in En
| MEDLINE
| ID: mdl-16533867
ABSTRACT
The present study aimed to systematically assess acute, dose-related behavioural effects of an extract of guaraná plant for the first time in humans. This double-blind, counterbalanced, placebo-controlled study (n=26) assessed the acute mood and cognitive effects throughout the day of four different doses (37.5 mg, 75 mg, 150 mg and 300 mg) of a standardised guaraná extract (PC-102). Assessment included the Cognitive Drug Research computerized test battery and Bond-Lader mood scales. Guaraná improved secondary memory performance and increased alert and content mood ratings. The two lower doses produced more positive cognitive effects than the higher doses. This research supports previous findings of cognitive improvements following 75 mg guaraná and provides the first exploration of different dose effects of guaraná in humans. The findings suggest that the effects cannot be attributed to caffeine alone.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psychotropic Drugs
/
Theobromine
/
Theophylline
/
Caffeine
/
Cognition
/
Affect
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Psychopharmacol
Journal subject:
PSICOFARMACOLOGIA
Year:
2007
Document type:
Article
Affiliation country:
Reino Unido